Department of Surgery and Science, Graduate School of Medicine, Kyushu University, Fukuoka, Japan.
Ann Surg Oncol. 2010 Oct;17(10):2740-6. doi: 10.1245/s10434-010-1076-2. Epub 2010 Apr 22.
The aim of this study was to elucidate the predictors of extrahepatic hepatocellular carcinoma (HCC) recurrence after hepatectomy.
A cohort of 252 patients with HCC who underwent hepatectomy following a recurrence were reviewed. The patients were categorized into 2 groups according to the pattern of their initial recurrence. Clinicopathological and survival data were compared between the groups.
Of the 252 patients, 218 had intrahepatic recurrence (IHR) (86.5%) and 34 had extrahepatic recurrence (EHR) (13.5%) as their initial recurrence. The mean duration of time until the initial recurrence after hepatectomy of the EHR and IHR groups was 1.8 and 2.2 years, respectively. The rate of recurrence within 6 months after hepatectomy of EHR and IHR groups was 35.3 and 14.2%, respectively (P = .002). The 3-, 5-, and 10-year cumulative survival rates of EHR group were 60.3, 24.0, and 6.0%, respectively, which were significantly lower than that of IHR group (74.5, 57.7, and 23.1%, P = .004). A multivariate analysis showed that blood loss during surgery and microscopic hepatic vein invasion remained as independent risk factors for increased EHR after hepatectomy for HCC. Furthermore, the combination of these 2 independent factors showed a significant association with the EHR.
EHR of HCC was associated with early recurrence and a poor survival after a hepatectomy. The combination of 2 independent factors for EHR, the presence of microscopic hepatic vein invasion and the blood loss during surgery, may be useful for predicting the risk for occurrence of EHR during the follow-up period.
本研究旨在阐明肝癌(HCC)切除术后肝外 HCC 复发的预测因素。
回顾性分析了 252 例 HCC 患者行肝切除术后复发的病例。根据初始复发模式将患者分为两组。比较两组的临床病理和生存数据。
在 252 例患者中,218 例(86.5%)为肝内复发(IHR),34 例(13.5%)为肝外复发(EHR)。EHR 和 IHR 组患者肝切除术后首次复发的平均时间分别为 1.8 年和 2.2 年。EHR 和 IHR 组患者肝切除术后 6 个月内的复发率分别为 35.3%和 14.2%(P=0.002)。EHR 组的 3、5 和 10 年累积生存率分别为 60.3%、24.0%和 6.0%,明显低于 IHR 组(74.5%、57.7%和 23.1%,P=0.004)。多因素分析显示,手术中失血量和镜下肝静脉侵犯是 HCC 肝切除术后 EHR 增加的独立危险因素。此外,这两个独立因素的结合与 EHR 有显著相关性。
EHR 与 HCC 肝切除术后早期复发和生存不良有关。EHR 的 2 个独立因素(镜下肝静脉侵犯和手术中失血量)的组合可能有助于预测随访期间 EHR 的发生风险。